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Objective: Puberty is a key developmental phenomenon highly sensitive to metabolic modulation. Worrying trends of changes in the timing of
puberty have been reported in humans. These might be linked to the escalating prevalence of childhood obesity and could have deleterious
impacts on later (cardio-metabolic) health, but their underlying mechanisms remain unsolved. The neuropeptide a-MSH, made by POMC neurons,
plays a key role in energy homeostasis by mediating the actions of leptin and likely participates in the control of reproduction. However, its role in
the metabolic regulation of puberty and interplay with kisspeptin, an essential puberty-regulating neuropeptide encoded by Kiss1, remain largely
unknown. We aim here to unveil the potential contribution of central a-MSH signaling in the metabolic control of puberty by addressing its role in
mediating the pubertal effects of leptin and its potential interaction with kisspeptin.
Methods: Using wild type and genetically modified rodent models, we implemented pharmacological studies, expression analyses, electro-
physiological recordings, and virogenetic approaches involving DREADD technology to selectively inhibit Kiss1 neurons, in order to interrogate the
physiological role of a putative leptin/a-MSH/kisspeptin pathway in the metabolic control of puberty.
Results: Stimulation of central a-MSH signaling robustly activated the reproductive axis in pubertal rats, whereas chronic inhibition of mela-
nocortin receptors MC3/4R, delayed puberty, and prevented the permissive effect of leptin on puberty onset. Central blockade of MC3/4R or
genetic elimination of kisspeptin receptors from POMC neurons did not affect kisspeptin effects. Conversely, congenital ablation of kisspeptin
receptors or inducible, DREADD-mediated inhibition of arcuate nucleus (ARC) Kiss1 neurons resulted in markedly attenuated gonadotropic re-
sponses to MC3/4R activation. Furthermore, close appositions were observed between POMC fibers and ARC Kiss1 neurons while blockade of a-
MSH signaling suppressed Kiss1 expression in the ARC of pubertal rats.
Conclusions: Our physiological, virogenetic, and functional genomic studies document a novel a-MSH/kisspeptin/GnRH neuronal signaling
pathway involved in transmitting the permissive effects of leptin on pubertal maturation, which is relevant for the metabolic (and, eventually,
pharmacological) regulation of puberty onset.
 2016 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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with reduced life expectancy [5]. Recent reports documented that
earlier puberty is linked to a higher risk of cardio-metabolic disease,
including hypertension and type-2 diabetes, in both men and women
[4]. Although the underlying mechanisms remain ill defined, the higher
prevalence of childhood obesity has been suggested to underlie the
trend of earlier puberty in humans [2,3]. In turn, puberty onset is
frequently coupled to decreased physical activity and behavioral
changes, including unhealthy nutritional habits, which predispose to or
worsen the development of obesity. These associations warrant a
better understanding of the basis of puberty and its deviations.
The timing of puberty is dictated by the concerted activation of the
hypothalamicepituitaryegonadal (HPG) axis, in which a scarce pop-
ulation of hypothalamic neurons secreting gonadotropin-releasing
hormone (GnRH) becomes fully active during the pubertal transition
to drive pituitary gonadotropin secretion and, thereby, complete
gonadal maturation and function [6]. Among the different pubertal
regulators, nutritional and metabolic cues have been shown to play a
critical role in the central control of puberty [7,8]. However, strong
evidence suggests that despite their hierarchical role, GnRH neurons
are not targeted directly by metabolic signals, such as leptin and in-
sulin [9], but are modulated indirectly by mostly unidentified inter-
mediary inputs.
Kisspeptin, the neuropeptide encoded by the Kiss1 gene and signaling
through Gpr54 (aka, Kiss1r), has been recognized recently as a
master puberty-activating factor [10,11]. Kiss1 neurons, which in
rodents are predominantly located in the arcuate nucleus (ARC) and
the rostral periventricular area of the third ventricle (RP3V), are
essential upstream afferents to GnRH neurons that play an important
role in transmitting the regulatory actions of key signals, including
metabolic cues [6,12]. Indeed, hypothalamic Kiss1/kisspeptin
expression is sensitive to conditions of metabolic stress, ranging from
subnutrition to obesity [6,13,14]. However, Kiss1 neurons apparently
do not express substantial amounts of leptin receptors [15], sug-
gesting that leptin does not signal directly to Kiss1 neurons to
modulate puberty onset.
Neurons in the ARC expressing the proopiomelanocortin (POMC) gene
are essential first-order elements in the central networks governing
body weight and energy homeostasis [16]; the major ARC POMC
product being a-melanocyte stimulating hormone (a-MSH). The cen-
tral effects of a-MSH are mediated via interaction with melanocortin
receptor (MCR) subtypes, MC3R and MC4R, which are expressed in the
hypothalamus and other brain areas [17]. Some evidence in adults
suggests that a-MSH signaling is involved in the control of the
reproductive axis. For example, POMC neurons are sensitive to a range
of metabolic hormones regulating the HPG axis, such as leptin, insulin,
and ghrelin [18], and POMC terminals form synapses with GnRH
neurons [16]. However, the actual gonadotropic effects of POMC
peptides seem to be variable; while a-MSH can activate GnRH neurons
and LH secretion, inhibitory effects have been also reported [16,19].
Mice with inactivation of Pomc, Mc3r or Mc4r not only develop obesity
but also subfertility (especially the females) by adulthood [19e21].
Admittedly, the reproductive phenotype of isolated inactivation of Mc3r
or Mc4r is mild, suggesting that the lack of one receptor could be
partially compensated by the other. Yet, mice harboring the agouti
lethal yellow (Ay) mutant allele that causes over-expression of the
agouti-protein, which is similar to the endogenous antagonist of MC3/
4R, agouti-related peptide (AgRP), are infertile [22]. Moreover, AgRP
has been suggested to interfere the permissive effect of leptin on the
reproductive axis [23,24]. Yet, the pathways mediating the reproduc-
tive effects of a-MSH remain unsolved, and its role in the metabolic
control of puberty is largely unexplored.MOLECULAR METABOLISM 5 (2016) 844e857  2016The Author(s). Published by Elsevier GmbH. This is an ope
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but the data available remain inconclusive. POMC and Kiss1 neurons
appear to make mutual contacts in the adult ovine brain, and a-MSH
enhanced Kiss1 mRNA levels in the preoptic area of sheep, whereas it
decreased Kiss1 expression in the ARC [25]. In mice, a subset of RP3V
Kiss1 neurons express the melanocortin receptor, MC4R [26].
Conversely, kisspeptin has been shown to inhibit Pomc gene expres-
sion in the ARC of the sheep [27], while ARC POMC neurons displayed
increased firing after kisspeptin stimulation in mice [28]. Hence, it is
difficult at present to delineate the physiological relevance of a-MSH/
kisspeptin interactions in adults and even less so in the context of
puberty. We provide herein an integrated analysis of the role of central




Wistar rats and genetically modified mice, including global Gpr54/
[29], POMC-specific Gpr54 KO (see below), and Kiss1-CreGFP [30]
lines, bred in the vivarium of the University of Cordoba, as well as
kisspeptin-IRES-Creþ//ROSA26-CAGS-sGFPþ/ (Kiss-GFP) mice
[31], bred in the animal facilities of the University of Otago, were used.
The animals were housed under constant conditions of light (12 h light/
dark cycles) and temperature (22  2 C). The day the litters were
born was considered day 1 of age (postnatal day 1; PND-1). Animals
were weaned at PND-21 and were provided with a free access to tap
water and fed ad libitum with a standard soy-free diet, unless other-
wise is indicated. The experiments and animal protocols included in
this study were approved by the Ethical Committees of the University of
Cordoba and the University of Otago; all experiments were conducted
in accordance with European Union normative for the use and care of
experimental animals (EU Directive 2010/63/UE, September 2010).
2.2. Drugs
The MC3/4R agonist, Melanotan (MT-II), the selective MC4R agonist,
Cyclo (b-Ala-His-d-Phe-Arg-Trp-Glu)-NH2, the MC3/4R antagonist,
SHU9119, and kisspeptin110-119-NH2 (termed hereafter kisspeptin-
10 or Kp-10) were purchased from Phoenix Pharmaceuticals Inc.
(Burlingame, CA, USA). The selective MC3R agonist D-Trp-g MSH was
obtained from American Peptide Company Inc. (Sunnyvale, CA, USA).
Recombinant rat leptin was obtained from ProSpec-Tany TechnoGene
Ltd. (Ness Ziona, Israel), and 17b-estradiol (E2) and clozapine-N-oxide
(CNO) were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
All the drugs were dissolved in physiological saline (0.9% NaCl), except
E2, which was dissolved in olive oil.
2.3. Treatments and experimental design
The experimental studies included herein were implemented to
investigate the putative function of a-MSH signaling in the control of
the gonadotropic axis at puberty and to explore their potential inter-
action with leptin and kisspeptin signaling. Central administration of
the different compounds was implemented using standard procedures
of cannulation and acute or repeated intracerebroventricular (icv) in-
jection, following previously published procedures [32,33]. In brief, rats
and mice were subjected to icv cannulation 24 h before the beginning
of the pharmacological studies; to this end, cannulas (INTRADEMIC
polyethylene Tubing, Becton Dickinson, Sparks, MD, USA) were
inserted to a depth of 2 mm beneath the surface of the skull, with an
insert point at 1 mm posterior and 1.2 mm lateral to Bregma, ac-
cording to a rat/mouse brain atlas [34]. After cannulation, they weren access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 845
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samples for hormone assays were obtained by jugular venipuncture,
unless otherwise is stated.
The following experimental studies, grouped into three major sets,
were conducted:
Experimental Set #1: Impact of pharmacological manipulation of
central a-MSH signaling on gonadotropin secretion and puberty onset
in immature rats. The acute effects of central activation of a-MSH
signaling on LH release were explored in infantile and peri-pubertal
rats in Experiment 1. To this end, an effective dose of MCR-3/4
agonist Melanotan (MT-II, 1 nmol), defined on the basis of previous
references [35], was icv injected to infantile (PND-15) male and female
rats, and animals were euthanized 15 min after the injection for trunk
blood collection. Similarly, peripubertal male (PND-43) and female
(PND-29) rats were icv injected with a single bolus of 1 nmol MT-II, and
blood samples were collected before (0) and after 15-, 30- & 60-min
(the later time-point, only in males) of MT-II injection. At both age-
points, control groups injected with vehicle were included.
Based on initial results, acute LH responses to a similar dose of MT-II
were explored in peripubertal male and female rats subjected to
metabolic stress, due to short-term fasting (Experiment 2). Food
deprivation was applied for a maximum of 48-h, and icv injection of
MT-II and serial blood sampling was conducted as for Experiment 1.
On the other hand, in Experiment 3, the individual contribution of the
major central melanocortin receptors, namely MC3R and MC4R, to LH
responses to MT-II was explored. To this end, peripubertal male rats
were icv injected with a range of doses (0.2, 1.0 and 5.0 nmol/rat) of
the selective MC3R (D-Trp-g MSH) or MC4R [Cyclo (b-Ala-His-d-Phe-
Arg-Trp-Glu)-NH2] agonists, and blood sampling was conducted before
(0), and 15-, 30- and 60-min after MT-II injection, as described above.
In addition, the effects of chronic blockade of a-MSH signaling on
puberty onset were explored in Experiment 4. Immature female rats
received two daily icv injections of the MCR-3/4 antagonist, SHU9119
(1 nmol/12 h/rat), or vehicle between PND-28 to PND-35. The dose of
the antagonist was selected based on a previous reference [36]. Since
pilot experiments revealed that repeated central administration of
SHU9119 resulted in significant increases in food intake and body
weight (BW) gain during the pubertal transition, SHU9119-treated
animals were pair-fed with vehicle-treated rats in order to avoid the
plausible influence of changes in BW on puberty onset. BW and vaginal
opening (VO) were daily monitored during the treatment. Animals were
sacrificed at PND-35, 60 min after the last injection of SHU9119 or
vehicle, and trunk blood, uteri, and ovaries were collected. In the same
vein, in Experiment 5, we explored the possible role of central a-MSH
signaling in mediating leptin effects on pubertal timing. To this end,
immature female rats were subjected from PND-23 to a moderate
state of negative energy balance, imposed by 20% restriction of daily
calorie intake (under-nutrition: UN group), as a means to decrease
endogenous leptin levels, in keeping with previous references [32,33].
Groups of UN rats received two daily icv injections of vehicle, leptin
(3.1 mg/12 h/rat) or leptin in combination with SHU9119 (1 nmol/12 h/
rat) between PND-29 and PND-35. Animals fed ad libitum (NN) and
injected with vehicle served as controls. BW and VO were daily
monitored. On PND-35, animals were killed by decapitation, 60-min
after the last injection, and trunk blood, ovaries and uterus were
collected.
Experimental Set #2: Assessment of the potential role of central a-
MSH signaling as mediator of kisspeptin effects on gonadotropin
secretion and puberty onset. In this set, we first evaluated acute LH
responses to central administration of Kp-10 after blockade of MC3/4R
in Experiment 6. To this end, peripubertal male rats were icv injected846 MOLECULAR METABOLISM 5 (2016) 844e857  2016 The Author(s). Published by Elsevier GmbH. Twith vehicle or SHU9119 (1 nmol/rat), at 120-min and 60-min before
administration of a third bolus of vehicle or SHU9119, alone or in
combination with 100 pmol/rat Kp-10; the dose of Kp-10 was selected
on the basis of previous references to obtain a submaximal LH
secretory response [32]. In parallel, groups of SHU9119-treated rats
were co-injected with MT-II (1 nmol/rat), as a means to check the
efficiency of MC3/4R blockade in our pharmacological setting. Blood
samples for hormone assays were obtained at 0-min (basal), and 15-
min and 60-min after Kp-10 or MT-II injection.
In addition, in Experiment 7, LH responses to Kp-10 were studied in a
novel mouse line with conditional ablation of the kisspeptin receptor
Gpr54 in POMC neurons (See Methods 2.4 for details of generation and
genotyping of this novel line). Male POMC-Gpr54 null mice and their
corresponding WT controls were subjected to icv cannulation, as
described above. The animals were icv injected with Kp-10 (50 pmol/
mouse) or vehicle, and blood samples were obtained at 15-min for
hormone analysis. As a continuation of this initial study, in Experiment
8, pubertal progression was examined in KO and WT female mice. To
this end, body weight gain was monitored postnatally, and the animals
were examined daily for vaginal opening after weaning; vaginal smears
were collected from the day of VO onwards for determination of the
occurrence of first estrus by cytological examination, VO and first
estrus being consensus sign of puberty onset.
Experimental Set #3: Assessment of the role of kisspeptin signaling as
mediator of a-MSH effects on gonadotropin secretion and puberty
onset. To cover this goal, we first conducted neuroanatomical studies
to identify the potential physical interplay between POMC and Kiss1
neurons. Thus, in Experiment 9, pubertal female rats (PND-33) were
perfused with 4% paraformaldehyde (PFA), following standard pro-
tocols and the brains were collected upon decapitation for immuno-
histochemical analyses, as described in detail below. In addition, we
assayed the impact of blockade of central a-MSH signaling on hy-
pothalamic Kiss1 mRNA levels was in Experiment 10. This experiment
was conducted in pubertal female rats. To avoid the potential con-
founding factor of changes in circulating estrogen on Kiss1 mRNA
expression [37], female rats were subjected on PND-25 to bilateral
ovariectomy (OVX) and supplemented with E2 by implanting SILASTIC
brand silicon tubing elastomers (Dow Corning, Midland, MI; 10 mm
length; inner diameter, 0.062 cm; exterior diameter, 0.125 cm) con-
taining E2 (10 mg/ml in olive oil), in line with previous references [32].
This dose of E2 was selected to achieve moderate levels of circulating
E2. Subsequently, the animals received two daily icv injections of
SHU9119 (1 nmol/rat) or vehicle between PND-28 and PND-32.
SHU9119-treated animals were pair fed to vehicle-treated rats, as
was described in Experiment 4. BW was daily monitored and, at the
end of the treatment, animals were euthanized and brains were
removed, frozen on dry ice and store at 80 C for posterior in situ
hybridization (ISH) analyses, as described in detail below.
To provide further functional evidence for this putative a-
MSH/Kiss1/kisspeptin pathway, pointed out by previous experi-
ments, in Experiment 11, we studied the effect of MT-II on LH release
in a global Gpr54 KO mouse model, which is defective for kisspeptin
signaling [29]. Two-month-old Gpr54 KO male mice and their corre-
sponding WT controls were used. To exclude the possibility that
defective gonadotropin response might derive from insufficient pitui-
tary responsiveness to GnRH due to the low endogenous GnRH tone in
this mouse line, Gpr54 KO mice were subjected to a protocol of GnRH
priming during two days before the test, following a previously pub-
lished priming protocol [29]. Priming protocols consisted of five suc-
cessive intra-peritoneal (ip) injections of a low dose of GnRH (0.15 mg/
mouse), with the following schedule: at 10:00 h, 17:00 h, and 24:00 hhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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on day 1; and at 08:00 h and 16:00 h on day 2. WT mice injected with
vehicle, following the same protocol, served as controls. Forty-eight
hours after beginning the priming, Gpr54 KO and WT male mice
received a single icv bolus of vehicle or MT-II (1nmol/mouse), and
blood samples were collected 15-min after the injection.
In Experiment 12, we studied the effect of MT-II on LH release after
silencing ARC kisspeptin neurons by the use of Cre-dependent
DREADDs (Designer Receptor Exclusively Activated by Designer
Drugs). An adeno-associated virus (AAV) was used to target the
pharmacogenetic activity-silencer receptor hM4D [38] to Kiss1
neurons at the ARC. In detail, AAV carrying Cre-dependent hM4D
receptor (AAV8-hSyn-DIO-hM4D-(Gi)-mCherry; UNC Vector Core)
were injected bilaterally in the ARC (from Bregma AP: 1.6 mm; L:
0.2 mm; DV: 5.8 mm) of adult male Kiss1-Cre mice [30]. Ani-
mals with mistargeted injections of the AAV were used as controls.
Following infection, hM4D receptors were activated by ip injection of
its agonist, CNO. Mice were subjected to subsequent pharmaco-
logical tests, with intervals of four days, starting on week 2 after the
AAV injection. In brief, on day 1, blood samples for hormone assays
were obtained at basal conditions. On day 5, Kiss1-Cre mice
received a single icv injection of MT-II (1nmol/mouse), and blood
samples were collected 15-min after the injection. On day 9, animals
received two ip injections of CNO (0.3 mg/kg), 30-min and 5-min
prior icv administration of a single bolus of MT-II (1 nmol), and
blood samples were collected 15-min after MT-II injection. Finally,
on day 13, the animals received two ip injections of CNO (0.3 mg/
kg), 30-min and 5-min before icv administration of vehicle, and
blood samples were collected 15-min later. At the end of the
experiment, mice were perfused and the brains were collected for
immunohistochemical (IHC) analyses (see below).
Finally, in Experiment 13, electrophysiological analyses were under-
taken in acute brain slices to determine the effect of MT-II on the
spontaneous action potential firing of ARC Kiss1 neurons. Pre-pubertal
(PND 23e26) and adult (2e3-month-old) female Kiss1-IRES-Creþ/
/ROSA26-CAGS-sGFPþ/ (Kiss1-GFP) mice [31] were used in these
studies. In adult mice, estrous cycle stage was determined by daily
vaginal smear each morning, and mice with at least two regular 4- or
5-day estrous cycles were selected for studies conducted on diestrus.
Absence of VO in PND23-26 females confirmed that these mice were
pre-pubertal. Electrophysiological recordings were performed as
described below.
2.4. Generation of a POMC neuron-specific Gpr54 null mouse line
To address the potential role of a-MSH signaling in transmitting
kisspeptin effects, mice lacking Gpr54 specifically in POMC neurons
were generated by crossing animals carrying Cre recombinase
expression under the POMC promoter, the POMC-Creþ/ mouse
[39], with mice with LoxP sites flanking the exon two of Gpr54
(Gpr54loxP/loxP mouse [40]). The well-characterized POMC-Cre mice
ensure functional Cre recombinase expression in >90% of arcuate
POMC neurons, while efficiency of the Gpr54loxP/loxP mouse to allow
conditional, Cre-dependent ablation of the kisspeptin receptor is also
well proven [29]. Thus, our approach guarantees that double mutant
mice will lack Gpr54 expression on the vast majority of ARC POMC
neurons.
POMC-Creþ/ mice were initially mated with Gpr54loxP/loxP animals.
The resulting genotypes, POMC-Creþ/; Gpr54loxP/, were self-
crossed to generate all the possible genotypic combinations. For the
experiments, only POMC-Creþ/; Gpr54loxP/loxP (referred as POMC-
Gpr54 KO mouse) and POMC-Cre/; Gpr54loxP/loxP (referred as con-
trols) were used.MOLECULAR METABOLISM 5 (2016) 844e857  2016The Author(s). Published by Elsevier GmbH. This is an ope
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POMC-Cre: POMC-Cre-1, 50-TGG CTC AAT GTC CTT CCT GG-30;
POMC-Cre-2, 50-CAC ATA AGC TGC ATC GTT AAG-30; POMC-Cre-3, 50-
GAG ATA TCT TTA ACC CTG ATC-30 resulting in a band of 1400-bp for
the endogenous allele POMC, and a band of 750-bp for the Cre allele.
Determination of Gpr54 LoxP alleles was done using the following
primers: pr13726, 50- CTC CCA ATG TGA CCT GGT G-30; pr14303 50-
CCT CGT GTC CCT CTG TGA TT-30; pr15168, 50- AAG ACC GGC TTA
GGG AGA TG-30 resulting in a 577-bp band for wild type, a 663-bp
band for the floxed allele, and a 800-bp band following recombina-
tion. For further details, see Supplementary Figure S1.
2.5. Kiss1 riboprobe synthesis
For detection of Kiss1 mRNA by in situ hybridization, a specific
riboprobe for Kiss1 rat mRNA, spanning 83e371 nt of the cDNA
sequence (GenBank NM_181692.1) was generated. First, a DNA
template was synthesized by PCR using specific primers for Kiss1
cDNA amplification carrying at their 50-end sequences for synthetic
promoters for bacteriophage-encoded DNA-dependent RNA
polymerases (T7 and T3). Primer sequences were as follows: forward
primer T3-Kiss sense (50-CAGAGATGCAATTAACCCTCACTAAAGG
GAGATGGTGAACCCTGAACCCACA-30); reverse primer T7-Kiss as
(50-CCAAGCCTTCTAATACGACTC ACTATAGGGAGAACCTGCCTCCTGCCG
TAGCG-30). For PCR reactions, Go Taq flexi DNA polymerase (Promega
Biotech) was used, following the recommendations of the manufac-
turer. Reactions were performed in an iCycler (Bio-Rad Laboratories,
Inc.) using the following protocol: cDNA was denatured for 5 min at
95 C, and then 4 cycles were performed at 94 C for 1 min, 54 C for
2 min and 72 C for 30 s, followed by 35 cycles at 94 C for 1 min,
65 C for 1 min and 72 C for 30 s. A final extension at 72 C for 5 min
was included. After electrophoresis on a 2% agarose (w/v) gel, a single
DNA fragment was obtained of the expected size and gel purified with
a QiaQuick gel extraction kit (Qiagen). For the generation of the anti-
sense Kiss1 riboprobe, the product of the PCR was used as template
for the transcription reaction, as follows (final volume of 20 ml): 250 Ci
[33P]-UTP (Perkin Elmer, Massachusetts, USA), 0.5 mg of template,
2 ml 3NTPs (5 mM rATP, rCTP and rGTP), 1 ml RNasin Ribonuclease
Inhibitor (Promega), 4 ml transcription buffer, and 2 ml T7 RNA poly-
merase (Promega). After 120 min of incubation at 37 C, another 1 ml
of T7 RNA was added to the mix, and the reaction was maintained for
an additional 60 min at 37 C. At the end, the residual DNA was
digested with 2 U DNase (Promega), and the reaction was terminated
by addition of 3 ml 0.5 M EDTA, pH 8.0. DEPC water was added to a
final volume of 50 ml, and the labeled riboprobe was purified using
illustra ProbeQuant G-50 Micro Columns (GE Healthcare, UK). For
synthesis of sense Kiss1 riboprobe, the same procedure was applied,
using T3 RNA polymerase (Promega).
2.6. In situ hybridization (ISH)
For analysis of the neuroanatomical distribution of Kiss1 mRNA
expression in the hypothalamus, brains were collected from selected
experimental groups and ISH analyses were performed, following
previous protocols [32,33]. Five sets of coronal 20-mm-thick sections
were generated and mounted on SuperFrost Plus slides (Thermo Fisher
Scientific Inc.). Standard procedures of tissue collection were applied,
starting on a fixed coordinate in the rostral hypothalamic area up to
ARC, to encompass equivalent areas including anterior and medial
portions of this nucleus where Kiss1 neurons are abundantly located
[34]. The samples were stored at 80 C until ISH analyses.
A specific antisense riboprobe for Kiss1 rat mRNA was used (see
details above). A single set of sections was used for ISH (adjacentn access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 847
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PFA for 15 min; (ii) stabilized with 0.1 M phosphate buffer (pH 7.4) at
room temperature for 10 min; (iii) treated with saline triethanolamine
and acetic anhydride to prevent non-specific binding of probes; (iv)
washed in 2 saline-sodium citrate (SSC) buffer for 3 min; (v)
dehydrated in increasing concentrations of ethanol; (vi) de-lipidated
with chloroform; and (vii) air dried at room temperature for 1 h. Af-
ter these steps, hybridization with Kiss1 riboprobe was performed for
16 h at 55 C. The hybridization buffer contained (for 40 ml): 25 ml
deionized formamide, 10 ml dextran sulfate 50%, 3 ml NaCl 5 M,
0.4 ml Tris base 1M (pH 8), 0.08 ml 0.5M EDTA (pH 8), 1 Denhardt’s
solution and RNase-free water up to 40 ml Kiss1 riboprobe was added
to the hybridization buffer to a final concentration of 0.03 pmol/ml
along with yeast tRNA. After hybridization, slides were: (i) washed with
4 SSC for 30 min; (ii) incubated in RNase-A buffer (Roche
Biochemical) at 37 C (32 mg/ml) for 1 h; (iii) equilibrated with 2 SSC
for 30 min; (iv) washed in 0.1 SSC for 1 h at 65 C; (v) dehydrated in
increasing ethanol series; and (vi) air dried at room temperature for
1 h. Finally, slides were dipped in Kodak Autoradiography Emulsion
type NTB (Eastman Kodak) and exposed for 1 week at 4 C in the dark.
After this, the sections were developed and fixed following the
manufacturer instructions (Kodak; Rochester, NY): (i) 4 min in Kodak
Developer D-19; (ii) 10 s in distilled water; (iii) 5 min in Kodak Fixer;
and (iv) 5 min in distilled water. For mounting, the sections were
previously dehydrated and rinsed with Sub-X Clearing Medium (Leica
Bio-systems). Then, slices were cover-slipped with Sub-X mounting
medium (Leica). For analysis, 50e60 sections from each animal (9e
10 slides; 6 sections/slide) were evaluated. Five animals per group
were included in the analysis. Slides were read under dark-field illu-
mination with custom-designed software enabled to count the total
number of cells (grain clusters). Cells were counted as Kiss1 mRNA
positive when the number of silver grains in a cluster exceeded that of
background.
2.7. Brain preparation for immunohistochemistry
Mice were anesthetized with ketamineexylazine and perfused intra-
cardially with saline (0.9% NaCl) followed by 4% PFA in PBS (pH 7.4).
Fixed brains were immersed in 30% sucrose and 0.01% sodium azide
in PBS at 4 C for 2e4 days. Next, 3 sets of coronal, 30 mm-thick
sections were cut in a freezing microtome Leica CM1850 UV and
stored at 20 C in cryo-protectant. For immunodetection of the
different proteins, one set of sections encompassing the whole hy-
pothalamus was used from each animal, and standard procedures for
single- or double-label immunohistochemistry was performed (see
below).
2.8. Single-label immunohistochemistry
Brains from mice injected with AAV8-hSyn-DIO-hM4D(Gi)-mCherry
were assessed for mCherry reporter expression to confirm bilateral
infection of ARC Kiss1 neurons with the AVV carrying Cre-dependent
hM4D receptor. One set of free-floating sections from each animal
was: (i) washed (3  10 min) in Tris-buffered saline (TBS) (pH 7.6) at
room temperature with gentle agitation; (ii) incubated with a primary
rabbit polyclonal anti-mCherry antibody 1:1000 (ab167453, Abcam) at
4 C for 48 h; (iii) washed (3  10 min) in TBS (pH 7.6) at room
temperature; (iv) incubated with a secondary biotinilated Donkey Anti-
Rabbit antibody 1:200 (JAC-711-066-152, Jackson Immunoresearch)
at room temperature for 90 min; (v) washed (3  10 min) in TBS (pH
7.6); (vi) incubated with Texas Red Streptavidin 1:200 (SA-5006,
Vector laboratories, Inc.) at room temperature for 90 min; and (vii)
washed (3  10 min) in TBS (pH 7.6). Thereafter, brain sections were848 MOLECULAR METABOLISM 5 (2016) 844e857  2016 The Author(s). Published by Elsevier GmbH. Tmounted on silane-coated slices, air dried, and cover-slipped with
Vectashield HardSet Mounting Medium (Vector Laboratories). No signal
was detected after applying secondary antibody in absence of primary
antibody. Immunoreactivity was visualized in a fluorescence micro-
scope Leica DM2500.
2.9. Double-label immunohistochemistry
For dual detection of POMC and kisspeptin immunoreactivity, one set
of brain sections was mounted on SuperFrost Plus slides (VWR In-
ternational). After drying for 1 h at 37 C, sections were washed in
PBS-T (0.1% Tween-20) for 10 min at room temperature then heated
in 10 mM sodium citrate (pH 6) for 10 min at 90 C to induce antigen
retrieval. Afterwards, sections were cooled to room temperature and
then washed 5 min in PBS. Sections were blocked in blocking buffer
(3% Donkey Serum, 0.4% Triton X-100) in PBS for 45 min at room
temperature. Next, sections were incubated overnight at 4 C with
primary sheep anti-rat/mouse kisspeptin antibody 1:10000 (AC #017;
gift from Dr Alain Caraty, PRC-INRA, 37380 Nouzilly, France) and with
primary rabbit anti-a-MSH antibody 1:1000 (T4434; Peninsula Labo-
ratories International, Inc.). Then, sections were washed in PBS and
incubated with secondary antibodies Alexa Fluor 488 Donkey Anti-
Sheep 1:500 (A11015, Invitrogen) and Alexa Fluor 555 Donkey Anti-
Rabbit 1:500 (A31572, Invitrogen), respectively, for 1 h at 37 C.
Slides were washed in PBS, immersed for 30 s in double distilled water
to remove salts and cover-slipped with Vectashield HardSet Mounting
Medium (Vector Laboratories). No signal was detected after applying
secondary antibodies in the absence of the primary antibody. Immu-
noreactivity analyses were made on a Nikon A1R FLIM confocal sys-
tem. Images were viewed and Z stacks condensed to 2D projections
using NIS-Elements Viewer software.
2.10. Cell-attached recordings
Coronal brain slices (200 mm thick) including the ARC were cut with a
vibratome (VT1000S; Leica) in an ice-cold solution containing (in mM):
NaCl 87, KCl 2.5, NaHCO3 25, NaH2PO4 1.25, CaCl2 0.5, MgCl2 6,
glucose 25 and sucrose 75. Slices were then incubated at 30 C for at
least 1 h in artificial cerebrospinal fluid (aCSF; in mM): NaCl 120, KCl 3,
NaHCO3 26, NaH2PO4 1, CaCl2 2.5, MgCl2 1.2 and glucose 10. All
solutions were equilibrated with 95%O2/5%CO2. Electrophysiological
recordings of ARC Kiss-GFP neurons were carried out as described
previously [41]. Briefly, slices were placed under an upright micro-
scope fitted for epi-fluorescence (Olympus, Tokyo, Japan) and
constantly perfused (1.5 ml/min) with warm (w30 C) aCSF. GFP-
expressing neurons were first visualized by brief fluorescence illumi-
nation and subsequently approached using infrared differential inter-
ference contrast optics. Spontaneous firing was recorded in voltage
clamp mode in the cell-attached configuration. Recording electrodes
(3e5 MU) were filled with aCSF including 10 mM HEPES. Low
resistance seals (10e30 MU) were achieved by applying the lowest
amount of suction required to detect spontaneous spikes. Electro-
physiological signals were recorded using a Multiclamp 700B amplifier
(Molecular Devices, Sunnyvale, CA) connected to a Digidata 1440A
digitizer (Molecular Devices). Signals were low-pass filtered at 3 kHz
before being digitized at a rate of 10 kHz and stored on a personal
computer. Signal acquisition was carried out with pClamp 10 (Mo-
lecular Devices). The spontaneous firing of ARC kisspeptin neurons
was monitored in control aCSF for >5 min before MT II was applied in
the bath for 1 or 5 min. In some experiments, the extracellular con-
centration of potassium ([Kþ]o) was increased by 10 mM to enhance
spontaneous firing. Cells displaying no spontaneous firing were
excluded from analysis if firing could not be evoked upon stimulationhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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with 20 mM KCl or 30 mM (S)-AMPA. Spontaneous spikes were
detected in pClamp 10. To determine the effect of MT II on ARC
kisspeptin neuron action potential firing, average firing rates were
compared over 1 min periods immediately before and 1e2 min
following application of the drug. MT II was considered to have an
effect if the firing rate changed by more than twice the standard de-
viation of the basal firing rate for a period longer than 1 min.
2.11. Hormone measurements
Serum LH levels in mice and rats were determined using double
antibody method and RIA kits supplied by the National Institute of
Health, NIH (Dr. Parlow, National Institute of Diabetes and Digestive
and Kidney Diseases National Hormone and Peptide Program,
Bethesda, MD, USA). Hormone provided by the NIH (LH-I-10) was
labeled with 125I using Iodo-gen method (Pierce, Rockford, IL). The
hormone concentrations were expressed using reference preparations
of LH-RP-3. The sensitivity of the assay was 75 pg/ml. Intra- and inter-
assay coefficients of variation (CV) were lower than 8%. The reliability
of the hormone determinations was confirmed by measurement of rat
serum samples with known concentrations of hormone of interest.
Serum leptin levels were measured using RIA kits from Linco Research
(St. Charles, MO) following manufacturer indications; the sensitivity of
the assays was 0.5 ng/ml.
2.12. Presentation of data and statistics
Data of BW, absolute and relative organ weights, ISH, hormonal levels,
and cell-attached recording values are expressed as the mean SEM.
Both time-course data and integral LH levels of different experimental
groups relative to the control groups were estimated as area under theFigure 1: Central activation of a-MSH signaling, preferentially via MC4R, stimulates LH s
injection of an effective dose (1 nmol) of the MC3/4R agonist MT-II on LH secretion in infant
to MT-II injection (icv, 1 nmol) in pubertal male (Panel B; n ¼ 12) and female (C; n ¼ 10
doses of selective MC3R (upper) or MC4R (lower) agonists in pubertal male rats (n ¼
calculated as AUC over the 60-min period after injection, are shown in the insets. * P < 0
animals (ANOVA followed by StudenteNewmaneKeuls multiple range test).
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conducted with a minimal total number of 7e12 determinations per
group. ISH and IHC assays were conducted with a minimum of 5
animals/group. Results were analyzed using Student t test or ANOVA
followed by StudenteNewmaneKeuls multiple range tests (Prism
GraphPad 5.0 software; GraphPad Software Inc., La Jolla, CA). Sig-
nificance level was set at P  0.05 and different letters or asterisks
indicate statistical significance. For cell-attached recording, compari-
sons between groups were carried out using Wilcoxon or Manne
Whitney tests with Prism GraphPad Software as appropriate. The
sample size used in tests was the number of neurons. Experiments
were replicated in at least three different mice in each group, and up to
three slices were used in each mouse. Differences were considered
significant for P values  0.05.
3. RESULTS
3.1. Central activation of a-MSH signaling stimulates LH secretion
in pubertal but not infantile rats
The central effects of a-MSH on the HPG axis were explored during the
infantileepubertal transition in rats by administering the MC3/4R
agonist, MT-II, and monitoring LH responses as a surrogate marker of
GnRH secretion. Intracerebroventricular (icv; 1 nmol/rat) injection of MT-
II to infantile (PND-15) male (n ¼ 10) and female (n¼ 10) rats failed to
change circulating LH levels (Figure 1A). In contrast, icv administration of
1 nmol MT-II to peripubertal male (PND-43; n ¼ 12) and female (PND-
29; n¼ 10) rats evoked significant 2e3 fold increases in LH secretion at
15-min, which persisted for 30-min after injection (Figure 1BeC). In
addition, the effects of MT-II were also tested in pubertal animalsecretion in pubertal but not infantile rats. (A) The effects of intracerebroventricular (icv)
ile (PND-15) male and female rats (n ¼ 10/group) are shown. In addition, LH responses
) rats are presented. (D, E) the effects on LH secretion of the icv injection of a range of
10/group) are depicted. In addition to time-course responses, integral LH responses,
.05, ** P < 0.01 and *** P < 0.001 vs. corresponding time-points in vehicle-injected
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gonadotropic function. As expected, LH levels were significantly
decreased in fasted male and female rats (n ¼ 12 and 10/group,
respectively). Nevertheless, icv MT-II continued to significantly increase
LH levels in these pubertal fasted rats (Supplementary Figure S2).
To examine the receptor subtype that mediates the above MT-II effects,
we evaluated LH responses to different doses of the selective MC3R
(D-Trp-g MSH) or MC4R [Cyclo (b-Ala-His-d-Phe-Arg-Trp-Glu)-NH2]
agonists in pubertal male rats. Both MC3R and MC4R agonists induced
significant changes in LH release in a dose-dependent manner. Low
doses (0.2- & 1-nmol; n ¼ 10/group) of the MC3R agonist evoked
significant (albeit modest) LH responses. In contrast, high doses (5-
nmol; n ¼ 10) of the MC4R agonist induced a significant increase in
LH levels that was similar in magnitude to that evoked by MT-II
(Figure 1DeE).
3.2. Central blockade of a-MSH signaling inhibits puberty onset
and prevents the permissive effects of leptin
The impact of chronic blockade of central a-MSH signaling on puberty
onset was evaluated in female rats by administering the pharmaco-
logical MC3/4R antagonist SHU9119 during the pubertal transition.
Initial experiments demonstrated that repeated icv injection ofFigure 2: Central blockade of a-MSH signaling inhibits puberty onset and prevents the perm
of the MC3/4R antagonist SHU9119 or vehicle on pubertal progression in immature femal
every 12-h between PND-29 to PND-35. Evolution of vaginal opening (VO), as external sig
ovarian (OW) weights and LH concentrations, in terminal (PND-35) samples are shown. (B) T
the MC3/4R antagonist SHU9119 in a rat model of moderate under-nutrition (UN) are displ
with vehicle, leptin, or leptin þ SHU9119 are shown. Data from age-matched female rats
purposes (n ¼ 9). For (A) * P < 0.05 vs. corresponding time-points in vehicle-injected a
different (P < 0.05; ANOVA followed by StudenteNewmaneKeuls multiple range test).
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weight (Supplementary Figure S3), illustrating the necessity of
endogenous central melanocortins for energy homeostasis during
puberty. Thus, to avoid the possible confounding effects of BW
changes on puberty onset, for further experiments, SHU9119-treated
animals were pair-fed to control animals. Accordingly, no differences
in body weight (BW) or circulating leptin levels were observed between
both groups at PND-35. Yet, SHU9119 administration from PND-28 to
PND-35 caused a marked delay in puberty onset with deferred
occurrence of vaginal opening (VO; n ¼ 10). Thus, while >75% of the
control, vehicle-treated females displayed VO at PND-35, only <13%
of SHU9119-treated animals showed complete VO at this age. This
effect was associated with a significant reduction in uterine and
ovarian weights, while LH levels also showed a non-significant ten-
dency to be lower in the SHU9119 group (Figure 2A).
Based on the above data, we evaluated the possibility that central a-
MSH signaling may mediate, at least in part, the effects of leptin on
puberty onset. This experiment was conducted in a model of chronic,
moderate under-nutrition (UN) from PND 23 onwards, in which
endogenous leptin levels are decreased and puberty/VO delayed, so
that the effects of replacement of leptin, as a permissive signal for
puberty onset, could be detected. Food-restricted animals wereissive effects of leptin. (A) The effects of repeated intracerebroventricular (icv) injection
e rats (n ¼ 10/group) are shown. Female rats were icv injected with 1 nmol SHU9119
nal of puberty, together with body weight and leptin levels, as well as uterus (UW) and
he effects of icv administration of repeated doses of leptin, alone or in combination with
ayed (n ¼ 10e14/group). In detail, BW, UW, and VO data from pubertal UN rats treated
fed ad libitum (normal nutrition: NN) and injected with vehicle are shown for reference
nimals (Student t-test); for (B) groups with different superscript letters are statistically
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subjected, from PND 29 to PND 35, to repeated central injections of
vehicle or leptin, alone (n ¼ 14 and 10, respectively) or in combination
with SHU9119 (n¼ 10). Females fed ad libitum and chronically treated
with vehicle served as controls (n ¼ 9). Chronic UN induced a sig-
nificant reduction of BW as well as relative uterine and ovarian weights,
lowered circulating LH levels, and delayed puberty onset (Figure 2B;
ovarian data are not shown). Administration of leptin to UN animals
was able to rescue, to a large extent, the negative effect of subnutrition
on pubertal timing (estimated by VO) and completely reversed the
decrease in relative uterine weight, despite inducing further decreases
in BW. Interestingly, concomitant blockade of central MC3/4R signaling
prevented the rescue effect of leptin on the timing of VO, without
affecting uterine weight (Figure 2B). No significant differences in ter-
minal serum LH levels were detected among the UN groups (data not
shown).
3.3. a-MSH signaling does not mediate the stimulatory effects of
kisspeptin on puberty/gonadotropic axis
Considering the role of central a-MSH signaling in mediating effects of
leptin on puberty onset (our initial data), potential interactions with the
puberty-stimulating neuropeptide kisspeptin were explored. Based on
fragmentary data from ovine and mouse studies, the hypothesis that
kisspeptin might act, at least partially, via a-MSH pathways was
initially tested in various rodent models. First, we examined the effect
of kisspeptin-10 (Kp-10) on LH release after blockade of central MC3/
4R signaling by SHU9119 in pubertal female rats. Central pre-
administration of two boluses of SHU9119 caused a significant
decrease of LH levels (n ¼ 10), suggesting a role of endogenous a-
MSH in the maintenance of basal LH secretion at puberty. However,
while SHU9119 administration completely blocked the effect of MT-II
on LH secretion (n ¼ 10), blockade of a-MSH signaling did not
affect LH responses to kisspeptin (n ¼ 10) (Figure 3A).Figure 3: a-MSH signaling does not mediate the stimulatory effects of kisspeptin on pu
effective dose (1 nmol) of the MC3/4R antagonist SHU9119 on basal LH secretion and stim
decreased basal LH levels and fully prevented LH responses to the MC3/4R agonist MT-II
Kp-10. (B) A summary of phenotypic and hormonal indices from a mouse model of congen
(as external sign of puberty) nor the age of first estrus or the magnitude of LH responses t
that basal LH levels were not altered and are denoted as dotted line (right panel). *** P < 0
followed by StudenteNewmaneKeuls multiple range test).
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conducted phenotypic analyses of puberty and LH responses to kiss-
peptin in a novel mouse model with congenital ablation of the ca-
nonical kisspeptin receptor Gpr54 in POMC neurons. Details of
generation of this mouse line can be found in the Methods section.
POMC-Gpr54 null females failed to display overt alterations of BW
postnatally and during the pubertal transition (n ¼ 9). Similarly, pu-
bertal timing, assessed by the occurrence of VO and the age of first
estrus, as an additional sign of first ovulation, was not altered by
congenital ablation of Gpr54 from POMC neurons (n ¼ 9). Finally, LH
responses to a bolus of Kp-10, which generated a >8-fold increase
over basal levels, were similar between WT (n¼ 7) and conditional KO
mice (n ¼ 7) (Figure 3B). Together, these data suggest that a-MSH
signaling is not likely to mediate the effects of kisspeptin on puberty
onset and gonadotropin secretion.
3.4. Kisspeptin signaling is a major mediator for the stimulatory
effects of a-MSH on puberty/gonadotropic axis
We next tested the hypothesis that a-MSH acts via kisspeptin path-
ways to modulate puberty and gonadotropin secretion. First, we per-
formed immunohistochemical analyses to identify whether physical
contacts between POMC and Kiss1 neurons exist in pubertal female
rats (n ¼ 4). As shown in Figure 4A, immunoreactive a-MSH fibers
were identified in close apposition to Kiss1 cell bodies, specifically in
the ARC of pubertal rats. This was a consistent observation across the
different ARC sections containing immunoreactive Kiss1 neurons and
the different individuals studied.
In addition, we studied the impact of chronic blockade of MC3/4R
signaling during the period of pubertal transition (PND-28 to PND-32)
on hypothalamic Kiss1 mRNA expression. To avoid the potential con-
founding factor of changes in circulating estrogen on Kiss1 expression,
immature female rats were subjected to bilateral OVX andberty/gonadotropic axis. (A) The effects of intracerebroventricular (icv) injection of an
ulated responses to MT-II and Kp-10 are presented (n ¼ 9e10/group). While SHU9119
in pubertal male rats, it did not affect LH responses to a submaximal (50 pmol) dose of
ital elimination of kisspeptin receptor Gpr54 from POMC neurons is shown. Neither VO
o Kp-10 were altered in mice with congenital ablation of Gpr54 in POMC neurons. Note
.001 vs. corresponding time-points in vehicle-injected animals (Student t-test or ANOVA
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In addition, in order to avoid the possible influence of changes of BW on
puberty onset, SHU9119-treated animals were pair-fed to control
animals. In keeping with previous studies, two main hypothalamic
populations of Kiss1-expressing neurons were detected in the ARC and
RP3V. Chronic administration of SHU9119 induced a significant sup-
pression (>45%) of Kiss1 mRNA levels in the ARC but not in the RP3V
of peripubertal female rats (Figure 4B; n ¼ 5/group).
To further document this potential a-MSH/kisspeptin pathway,
additional functional and electro-physiological analyses were con-
ducted in different female rodent models. Thus, the capacity of a-MSH
to elicit gonadotropic responses in the absence of kisspeptin signaling
was evaluated by studying the effect of MT-II on LH secretion in a
mouse line with congenital elimination of kisspeptin receptors, the
Gpr54 KO mouse line. While WT animals displayed robust LH secretory
responses to a single bolus of MT-II (n ¼ 12), LH responses to MT-II
were severely blunted, although not totally eliminated, in Gpr54-
deficient mice (n ¼ 7) (Figure 5A). Of note, Gpr54 null mice had
been subjected to a protocol of GnRH priming to achieve a state of
proper pituitary responsiveness, in line with a previous reference [29].
We next tested the ability of a-MSH signaling to stimulate LH secretion
after pharmacogenetic silencing of the ARC Kiss1 neurons using
DREADD technology. For this purpose, mice with Kiss1-Cre dependent,
viral-mediated over-expression of the pharmacogenetic Gi/o-coupled
receptor hM4D were injected with an effective dose of MT-II
(1 nmol; n ¼ 7), following synaptic silencing of Kiss1 neurons by
administration of the hM4D agonist, CNO (n¼ 7). In line with our initialFigure 4: Interplay between POMC/Kiss1 neurons and Kiss1 expression after blockade of a
analyses in different sections of the putative interactions between MSH-positive fibers (in m
rats. Reconstruction 3-D analysis of the particular example of Neuron-3 is shown at the bo
MC3/4R antagonist SHU9119 on Kiss1 mRNA expression in the ARC and RP3V of pubertal
every 12-h between PND-28 to PND-32. Kiss1 expression was assessed by ISH; besides
*P < 0.05 vs. corresponding values for each hypothalamic area in vehicle-injected anim
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elevated levels of LH, 15-min after the injection. In contrast, in the
presence of CNO, MT-II was found to be significantly less effective at
stimulating LH secretion in mice with effective viral targeting of the
ARC, as demonstrated by mCherry immunohistochemistry (Figure 5B).
This inhibition was not observed in mice with ineffective hM4D
expression in ARC Kiss1 neurons, as documented by the lack of
detectable mCherry signal at this site (n ¼ 7). Even assuming that the
entire ARC Kiss1 neuronal population might not have been effectively
infected with our viral approach (as suggested by the average number
of mCherry-positive cells; for a representative example, see Figure 5B),
altogether, the above findings strongly suggest that the stimulatory
effects of a-MSH on puberty and LH secretion are critically dependent
upon the activation of kisspeptin pathways. Of note, DREADD-
mediated inhibition of Kiss1 neurons alone resulted in a non-
significant tendency to lower basal LH levels (0.24  0.04 vs.
0.77  0.23 ng/ml in reference animals; P ¼ 0.06; n ¼ 7) in pubertal
female mice.
Finally, electrophysiological studies were undertaken to examine
whether a-MSH directly modulates the electrical excitability of ARC
Kiss1 neurons. Female ARC Kiss1 neurons displayed low levels of
spontaneous action potential firing with over half of the neurons being
completely silent and no differences detected in firing rates between
PND23-26 and adult diestrous mice. Because of the large proportion of
silent cells, the extracellular [KCl] was elevated to 13 mM (normally
3 mM) in some experiments to evoke a low level of spontaneous ac-
tivity. With one exception (Supplementary Figure S4E), 1e5 min bath-MSH signaling. (A) Three representative examples are shown of immunohistochemical
agenta) and kisspeptin (Kp)-positive cell bodies (in green) in the ARC of pubertal female
ttom of panel A. (B) The effects of repeated intracerebroventricular (icv) injection of the
female rats are presented. Female rats (n ¼ 5) were icv injected with 1 nmol SHU9119
representative photomicrographs, quantitative data are presented in the lower panels.
als (P < 0.05; Student t-test).
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applications of the MC3/4R agonist, MT-II (1 mM), did not change Kiss1
neuronal firing in PND23-26 (Supplementary Figure S4A,C; n ¼ 13) or
adult diestrous mice (Supplementary Figure S4B,D; n ¼ 36), regard-
less of the extracellular [KCl].
4. DISCUSSION
Melanocortin signaling has a key role in the central control of meta-
bolism and energy homeostasis [42,43]. In the present study, we
examined whether the role of a-MSH in signaling leptin levels within
the brain extended to the metabolic regulation of puberty onset. Using
a variety of techniques in both rat and mouse models, we provide here
the first evidence that the permissive influence of leptin on puberty
onset is mediated, at least in part, by an a-MSH/Kiss1/GnRH
neuron signaling pathway. Notably, while some studies had pharma-
cologically addressed the roles of a-MSH in the control of gonadotropin
secretion in adulthood [44] and direct effects of a-MSH on GnRH
neurons had been characterized in adult mice [45], the actual role of
melanocortin signaling in metabolic regulation of puberty remained
largely unexplored.
Our pharmacological experiments in immature rats, using acute LH
responses as a surrogate marker of GnRH neuron activation, have
demonstrated that the stimulatory actions of MC3/4R signaling on the
gonadotropic axis develop with postnatal age, as potent LH responsesFigure 5: Kisspeptin signaling is a major mediator for the stimulatory effects of a-MSH on
(1 nmol) of the MC3/4R agonist MT-II on LH secretion in WT mice and mice with conge
responses are presented from WT and KO animals, at 15-min after icv injection of MT-II. (B
mediated inhibition of Kiss1 neurons are shown. The first two bars correspond to control a
effectively infected with hM4-constructs in the ARC, following receptor activation by CNO ad
In addition, in the inset, the magnitude of LH responses to MT-II in animals without effec
(n ¼ 7/group). In the lower panels, representative photomicrographs of mCherry immunoh
targeting of the ARC nucleus are presented. In panel A, *P < 0.05 vs. corresponding time-p
different superscript letters are statistically different (ANOVA followed by StudenteNewm
MOLECULAR METABOLISM 5 (2016) 844e857  2016The Author(s). Published by Elsevier GmbH. This is an ope
www.molecularmetabolism.comto MT-II were detected in peri-pubertal but not in infantile rats. As
robust LH responses to melanocortin stimulation were only observed
with high doses of the selective MC4R agonist, it is possible that this
receptor subtype is primarily responsible for mediating the major
stimulatory actions of a-MSH on the gonadotropic axis at puberty.
Nevertheless, modest but significant LH-releasing effects of the MC3R
agonist were also detected, suggesting that both receptors may be
involved. In fact, such differences in the dose-responsiveness to both
receptor agonists might reflect a mechanism whereby the melano-
cortin system could provide a wider range of regulatory actions,
depending on a-MSH concentrations, with stimulatory effects being
mostly mediated via MC3R or MC4R at low or high concentrations,
respectively. In any event, the physiological relevance of such mela-
nocortin signaling was demonstrated by the fact that acute blockade of
MC3/4R resulted in the significant lowering of basal LH levels.
Furthermore, chronic inhibition of central melanocortin signaling dur-
ing the pubertal transition resulted in a marked delay of puberty onset,
as monitored by a combination of external and internal indices of
pubertal maturation. These gain- and loss-of-function experiments are
clearly indicative of a stimulatory role for a-MSH signaling in the
regulation of puberty in rats. Central administration of the antagonist
SHU9119 also caused a significant increase in daily food intake and
body weight in pubertal female rats, indicating a dual role for
endogenous melanocortin drive in the control of energy homeostasisLH secretion. (A) The effects of intracerebroventricular (icv) injection of an effective dose
nital inactivation of the kisspeptin receptor Gpr54 are shown (n ¼ 7e12/group). LH
) The effects on LH secretion of the icv injection of MT-II (1-nmol) in mice with DREADD-
nimals, infected with mock viral constructs; the following two bars correspond to mice
ministration (n ¼ 7/group). Responses in mice injected with vehicle or MT-II are shown.
tive infection with hM4 in the ARC (in the presence and absence of CNO) is displayed
istochemistry in mice with effective (AAV-hM4D ARCþ) or ineffective (AAV-hM4D ARC-)
oints in vehicle-injected animals; a P < 0.05 vs. corresponding WT values. Groups with
aneKeuls multiple range test).
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moting effects of SHU9119 had been previously reported in adult male
rats, no discernible impact of central melanocortin blockade on adult
gonadotropic function was detected [46], which might suggest that a-
MSH signaling plays a selective stimulatory role during pubertal
maturation.
Among the metabolic regulators of puberty, the adipocyte hormone
leptin is known to play an essential permissive role [47]. The fact that
central MC3/MC4 receptor activation could rescue the suppression of
basal LH levels in pubertal animals subjected to fasting is compatible
with a role of a-MSH signaling as transmitter for the pubertal/repro-
ductive effects of leptin, as its levels are suppressed in conditions of
negative energy balance linked to inhibition of reproduction, such as
fasting. This was further confirmed by our physiological experiments in
female rats that revealed that the permissive effects of leptin on pu-
berty onset, as monitored by VO, could be prevented by the
concomitant blockade of central a-MSH signaling. These data indicate
that a-MSH is a major down-stream signal for mediating the central
effects of leptin on pubertal awakening of the HPG axis. Intriguingly, the
reproductive effects of leptin apparently were not blocked by central
SHU9119 administration in adult male ob/ob mice [48], which again
points to a sex- and/or pubertal-specific role of such leptinemela-
nocortin pathway in terms of reproductive control.
Fragmentary evidence, mainly from adults, has suggested the interplay
between a-MSH and kisspeptin signaling. Our data demonstrate,
however, that Kiss1 neurons do not regulate POMC neurons to
modulate GnRH neuron activity at the time of puberty. Potent LH re-
sponses to even submaximal doses of Kp-10 were fully preserved
following MC3/4R blockade, and kisspeptin influence upon pubertal
timing and LH secretion was fully maintained in mice engineered to
lack Gpr54 selectively in POMC neurons. These observations are in line
with recent reports showing that direct kisspeptin actions on GnRH
neurons seem to be sufficient to attain puberty [40,49]. It is interesting
to note a prior electrophysiological study that reported effects of
kisspeptin on POMC neurons in the mouse [28]. The functional sig-
nificance of this input is not known but, on the basis of our present
experiments, it is unlikely to be involved in the regulation of GnRH
neurosecretion and the gonadal axis. It remains possible that direct
kisspeptin effects on POMC neurons might serve other functions, as
these have been suggested to underlie its eventual anorectic effects
[28,50]. Yet, this also seems improbable as our mice with conditional
ablation of Gpr54 from POMC neurons exhibit normal food intake and
body weight gain.
In clear contrast, our combination of neuroanatomical, functional, and
pharmacogenetic studies has unveiled an important melano-
cortin/kisspeptin/GnRH regulatory pathway involved in relaying
leptin actions and regulating puberty onset. In this pathway, Kiss1
neurons appear to play a prominent role in transmitting the stimulatory
effects of melanocortin signaling onto the reproductive centers, as
documented by (i) the presence of appositions between a-MSH fibers
and Kiss1 neuronal cell bodies in the ARC of pubertal female rats; (ii)
the reduction of Kiss1mRNA expression in the ARC of pubertal females
subjected to chronic blockade of MC3/4R; i.e., a protocol that inhibits/
delays puberty onset; (iii) the marked attenuation of LH responses to
MT-II in mice with congenital inactivation of Gpr54; and, importantly,
(iv) the lowering of LH responses to MT-II following DREADD-mediated
inhibition of ARC Kiss1 neurons. Considering that most ARC POMC
neurons are GABAergic, our data could explain, at least partially, recent
findings showing that selective ablation of leptin receptors from all
GABA neurons perturbs puberty onset and down-regulates ARC Kiss1
expression in mice [51,52].854 MOLECULAR METABOLISM 5 (2016) 844e857  2016 The Author(s). Published by Elsevier GmbH. TTo our knowledge, this is the first report assessing physiological as-
pects of Kiss1 neuronal function using DREADDs. Interestingly, we
noted a trend for suppressed basal LH levels following CNO admin-
istration in pubertal female mice with hM4D over-expression in ARC
Kiss1 neurons. Although not significant, this observation supports that
ARC Kiss1 neurons may be involved in the maintenance of basal
gonadotropin secretion at puberty [31]. Moreover, the unambiguous
suppression of LH responses to MT-II after DREADD-mediated inhibi-
tion of ARC Kiss1 neurons clearly supports the relevance of melano-
cortin regulation of kisspeptin output for mediating a-MSH actions on
GnRH neurons at puberty.
While the cellular mechanisms underlying the potent effects of kiss-
peptin on GnRH neurons are becoming increasingly well characterized
[53], the precise mode of action whereby a-MSH modulates Kiss1
neurons remains unknown. Interestingly, we found that a-MSH did not
exert any detectable effects on the firing of ARC Kiss1 neurons, sug-
gesting either that it acts indirectly or that a-MSH regulates ARC Kiss1
neurons without impacting upon their firing rate. Of note, activation of
metabotropic pathways or changes in intracellular signaling cascades
in Kiss1 neurons might not alter their electrical activity; for instance,
neurokinin B can modulate intracellular calcium levels in ARC Kiss1
neurons independent of action potential firing (De Croft & Herbison,
unpublished). In addition, our data could be suggestive of the
involvement of additional intermediary pathways connecting a-MSH
and Kiss1 neurons, which might not be preserved intact in our elec-
trophysiological brain slice preparation. One tenable candidate for such
intermediary elements might be nitric oxide (NO) producing neurons,
as neurons expressing NO synthase (nNOS) have been recently re-
ported to participate in mediating the permissive effects of leptin on
puberty onset in mice [54], and synaptic contacts have been
demonstrated between POMC and nNOS neurons [55].
Our findings also suggest a precise maturational program for the
melanocortin regulation of the gonadotropic axis. The lack of stimu-
latory effects of the agonist, MT-II, in infantile rats is in clear contrast to
the potent gonadotropin-releasing effects of kisspeptin detected in
male and female rats at the same age [56]. This implies that, although
the capacity of kisspeptins to activate GnRH neurons is achieved at
very early developmental stages, key upstream activators of endoge-
nous kisspeptin pathways such as a-MSH would become operational
only at later maturational periods coinciding with pubertal activation.
Interestingly, the switch between absent and detectable LH responses
to MT-II coincides with the pattern of developmental maturation of
Kiss1 neurons, at both ARC and RP3V nuclei, reported in rodents
during postnatal maturation [57e59]. While, as a whole, our findings
point to a predominant role of ARC Kiss1 neurons in mediating a-MSH
actions on pubertal onset, the eventual contribution of RP3V Kiss1
neurons in this phenomenon cannot be discarded and merits further
investigation.
It must be noted that, although severely blunted, detectable LH re-
sponses to the MC3/4R agonist were observed in Gpr54 null mice. This
suggests that part of the stimulatory effects of a-MSH on GnRH
secretion could be independent of kisspeptin signaling. Indeed, direct
electrical responses to a-MSH and MT-II have been recorded in GnRH
neurons [23,45]. Our present findings do not refute but rather are
compatible with such direct effects. Indeed, the diversity of sites of
action indicated by our data, via direct and indirect pathways
converging on GnRH neurons, suggests that central melanocortin
signaling serves an important evolutionary mechanism that ensures
the supply of relevant metabolic information to the reproductive cen-
ters in order to exquisitely fit reproductive maturation and fertility with
optimal metabolic conditions.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Mice with genetic inactivation of MC3R or MC4R display a variable
degree of fertility problems: MC3R KO female mice are sub-fertile,
while MC4R null mice, although fertile, are poor breeders and
show decreased ovulatory rates [60]. These observations suggest
that although a-MSH signaling might be dispensable to achieve
reproductive competence, it actually plays a discernible role in the
control of some functional aspects of the HPG axis. It must be
stressed, though, that detailed characterizations of puberty were not
conducted in those mouse lines and, as congenital KO models, they
may suffer from developmental compensation, a possibility that is
specially tenable in partially redundant systems, such as MC-Rs,
when only one element of the family (MC3R or MC4R) is ablated.
Notably, mice with functional blockade of both MC3R and MC4R, by
over-expression of the agouti protein have been shown to be infertile
[22], whereas ablation of AgRP rescues fertility in leptin receptor
deficient, db/db mice [23].
5. CONCLUSIONS
Our present data in wild type and genetically modified rodent models
provide a novel mechanistic insight into the melanocortin regulation of
pubertal maturation in the female by documenting a discernible lep-
tin/a-MSH/Kiss1/GnRH pathway, which appears to play an
important role in the metabolic control of puberty.
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